Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Libert

Showing results (51-60 of 245) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2017
Complete overview of protein-inactivating sequence variations in 36 sequenced mouse inbred strainsSteven Timmermans, Marc Van Montagu, Claude Libert
Cytokine & Growth Factor Reviews|March 11, 2011
Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progressionEline Dejonckheere, Roosmarijn E Vandenbroucke, Claude Libert
Brain, Behavior, and Immunity|June 28, 2015
Therapeutic implications of the choroid plexus-cerebrospinal fluid interface in neuropsychiatric disordersDelphine Demeestere, Claude Libert, Roosmarijn E Vandenbroucke
EMBO Molecular Medicine|May 19, 2011
The first MMP in sepsisRoosmarijn E Vandenbroucke, Lien Dejager, Claude Libert
European Cytokine Network|April 17, 2002
Mice lacking alpha(2)-macroglobulin show an increased host defense against Gram-negative bacterial sepsis, but are more susceptible to endotoxic shockTino Hochepied, Fred Van Leuven, Claude Libert
Nature|December 11, 2012
Human disease: Strength to strength for mouse modelsKlaus Schughart, Claude Libert, Martien J Kas
European Journal of Human Genetics : EJHG|May 2, 2013
Controlling complexity: the clinical relevance of mouse complex geneticsKlaus Schughart, Claude Libert, , et al.
Cytokine & Growth Factor Reviews|April 22, 2014
Regulation and dysregulation of tumor necrosis factor receptor-1Leen Puimège, Claude Libert, Filip Van Hauwermeiren
Cytokine & Growth Factor Reviews|October 4, 2011
Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1Filip Van Hauwermeiren, Roosmarijn E Vandenbroucke, Claude Libert
Endocrinology|February 7, 2013
New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivationSofie Vandevyver, Lien Dejager, Jan Tuckermann, et al.
Pageof 25

Showing results (51-60 of 245) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2017
Complete overview of protein-inactivating sequence variations in 36 sequenced mouse inbred strainsSteven Timmermans, Marc Van Montagu, Claude Libert
Cytokine & Growth Factor Reviews|March 11, 2011
Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progressionEline Dejonckheere, Roosmarijn E Vandenbroucke, Claude Libert
Brain, Behavior, and Immunity|June 28, 2015
Therapeutic implications of the choroid plexus-cerebrospinal fluid interface in neuropsychiatric disordersDelphine Demeestere, Claude Libert, Roosmarijn E Vandenbroucke
EMBO Molecular Medicine|May 19, 2011
The first MMP in sepsisRoosmarijn E Vandenbroucke, Lien Dejager, Claude Libert
European Cytokine Network|April 17, 2002
Mice lacking alpha(2)-macroglobulin show an increased host defense against Gram-negative bacterial sepsis, but are more susceptible to endotoxic shockTino Hochepied, Fred Van Leuven, Claude Libert
Nature|December 11, 2012
Human disease: Strength to strength for mouse modelsKlaus Schughart, Claude Libert, Martien J Kas
European Journal of Human Genetics : EJHG|May 2, 2013
Controlling complexity: the clinical relevance of mouse complex geneticsKlaus Schughart, Claude Libert, , et al.
Cytokine & Growth Factor Reviews|April 22, 2014
Regulation and dysregulation of tumor necrosis factor receptor-1Leen Puimège, Claude Libert, Filip Van Hauwermeiren
Cytokine & Growth Factor Reviews|October 4, 2011
Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1Filip Van Hauwermeiren, Roosmarijn E Vandenbroucke, Claude Libert
Endocrinology|February 7, 2013
New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivationSofie Vandevyver, Lien Dejager, Jan Tuckermann, et al.
Pageof 25